Patent details
EP3603669 Title: AQUEOUS FORMULATION, AQUEOUS FORMULATION IN INJECTOR, ANTIBODY PROTEIN DISAGGREGATING AGENT, AND ANTIBODY PROTEIN DISAGGREGATION METHOD
Basic Information
- Publication number:
- EP3603669
- PCT Application Number:
- JP2018013559
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP187756440
- PCT Publication Number:
- WO2018181876
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- AQUEOUS FORMULATION, AQUEOUS FORMULATION IN INJECTOR, ANTIBODY PROTEIN DISAGGREGATING AGENT, AND ANTIBODY PROTEIN DISAGGREGATION METHOD
- French Title of Invention:
- FORMULATION AQUEUSE, FORMULATION AQUEUSE DANS UN INJECTEUR, AGENT DE DÉSAGRÉGATION DE PROTÉINE D'ANTICORPS ET PROCÉDÉ DE DÉSAGRÉGATION DE PROTÉINE D'ANTICORPS
- German Title of Invention:
- WÄSSRIGE FORMULIERUNG, WÄSSRIGE FORMULIERUNG IN EINEM INJEKTOR, ANTIKÖRPERPROTEINDISAGGREGATIONSMITTEL UND ANTIKÖRPERPROTEINDISAGGREGATIONSVERFAHREN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 26/06/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 02/09/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 19/06/2024
- Unitary Effect Registration Date:
- 02/09/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 30/03/2018
- Grant date:
- 19/06/2024
- EP Publication Date:
- 05/02/2020
- PCT Publication Date:
- 04/10/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 19/06/2024
- EP B1 Publication Date:
- 19/06/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 30/03/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 12/06/2024
- Name:
- Dong-A Socio Holdings Co., Ltd.
- Address:
- 64, Cheonho-daero Dongdaemun-gu, Seoul 02587, Korea (Republic) (KR)
- Name:
- Meiji Seika Pharma Co., Ltd.
- Address:
- 4-16, Kyobashi 2-chome Chuo-ku, Tokyo 104-8002, Japan (JP)
Inventor
1
- Name:
- KAYA, Arpansiree
- Address:
- Japan (JP)
2
- Name:
- FUJITA, Michinari
- Address:
- Japan (JP)
Priority
- Priority Number:
- 2017070844
- Priority Date:
- 31/03/2017
- Priority Country:
- Japan (JP)
Classification
- IPC classification:
- A61K 39/395; A61K 9/08; A61K 47/18; A61K 47/26; A61P 17/06; A61P 37/02;
Publication
European Patent Bulletin
1
- Issue number:
- 202425
- Publication date:
- 19/06/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202431
- Publication date:
- 31/07/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202440
- Publication date:
- 02/10/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|